Nirvana Life Sciences Inc.
NIRV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.50K | -119.60K | -55.50K | -44.70K | -40.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00 | 11.10K | -19.90K | 20.30K | -100.00 |
| Change in Net Operating Assets | -668.60K | 90.50K | 65.40K | 3.40K | 40.20K |
| Cash from Operations | -695.20K | -18.00K | -9.90K | -21.00K | -800.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.00K | 70.20K | -42.90K | 37.60K | 5.30K |
| Total Debt Repaid | -- | 85.80K | -85.80K | -- | -- |
| Issuance of Common Stock | 950.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -800.00 | -- | -- | -- | -- |
| Cash from Financing | 694.50K | 109.80K | -90.60K | 27.60K | 3.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -84.70K | 95.60K | -9.10K | -2.20K |
| Net Change in Cash | -700.00 | 7.10K | -4.90K | -2.50K | 800.00 |